Concerns regarding data supporting recent Pneumocystis jirovecii prophylaxis guidelines

Annals of Hematology

Volumn 92, Issue 11, 2013, Pages 1569-1570

  Seymour, John F ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CLADRIBINE; PENTOSTATIN;

CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CLINICAL DECISION MAKING; CYTOPENIA; EVIDENCE BASED MEDICINE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LETTER; PNEUMOCYSTIS JIROVECII INFECTION; PNEUMOCYSTOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; NEOPLASMS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PRIMARY PREVENTION;

EID: 84885640807     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1743-z     Document Type: Letter

References (6)

1. Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfield-Toal M (2013) Primary prophylaxis of bacterial infections and Pneumocystis jiroveccii pneumonia in patients with hematological malignancies and solid tumors. Ann Hematol 92:433-442
2. Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Datbase Syst Rev 3, CD005590
3. Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clinic Proc 82:1052-1059
4. Kaplan JE, Hanson DL, Navin TR, Jones JL (1998) Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. J Infect Dis 178:1126-1132
5. Seymour JF, Kurzrock R, Freireich EJ, Estey EH (1994) 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906-2911
6. Seymour JF, Talpaz M, Kurzrock R (1997) Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-α-resistant hairy cell leukemia: seven year follow-up. Leukemia 11:42-47